Four Boston area Israeli collaborations receive $1.3 in funding for innovative medical and energy projects under new MA/Israel partnership.
Tag: pr
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
Newsrooms Must Adopt “Innovation Culture” To Survive, Google Exec says
Cambridge writer Anita Harris reports on Google News Exec’s advice to newspaper industry at Nieman Foundation, May 11, 2012
Dance Review: Alvin Ailey in Boston: Stunning Integration of Past, Present, Future.
Anita Harris, New Cambridge Observer, reviews Alvin Ailey American Dance Theater performance of April 28, 2012.
Downturn + changing VC industry = funding challenges for startups
The economic recession of 2008 has led to soul-searching and innovation in the venture capital industry – to challenges for startups seeking funding, Boston VCs report .
Bio-IT World Review: BIG Data; BIG Promise; BIG CHALLENGES.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.
“Elevator pitching is like dating,” CIC’s Tim Rowe tells HarrisCom Workshop
Tim Rowe, CEO of the Cambridge Innovation Center tells Harris Communications Group workshop: “Elevator pitching is like dating”